Sangamo Therapeutics, Inc. (SGMO)
0.4633
-0.02
(-4.00%)
USD |
NASDAQ |
Dec 11, 15:40
Sangamo Therapeutics Free Cash Flow: -76.40M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Novavax, Inc. | -384.71M |
| Arcturus Therapeutics Holdings, Inc. | -61.54M |
| Pfizer Inc. | 10.38B |
| AIM ImmunoTech, Inc. | -13.33M |
| Protalix Biotherapeutics, Inc. | -11.69M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -28.50M |
| Cash from Investing (Quarterly) | -0.064M |
| Cash from Financing (Quarterly) | 19.20M |
| Free Cash Flow Per Share (Quarterly) | -0.0939 |
| Free Cash Flow to Equity (Quarterly) | -30.52M |
| Free Cash Flow to Firm (Quarterly) | -28.56M |
| Free Cash Flow Yield | -66.51% |